At a glance
- Originator Pfizer
- Class Antiepileptic drugs; Anxiolytics; Azoles; Benzodiazepines; Hypnosedatives; Small molecules
- Mechanism of Action GABA A receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Anxiety disorders
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Anxiety-disorders(In volunteers) in India (Sublingual, Tablet)
- 16 Jul 2016 No recent reports of development identified for phase-I development in Anxiety-disorders(In volunteers) in USA (Sublingual, Tablet)
- 01 Mar 2015 Pfizer terminates phase I trial in Anxiety disorders in India prior to enrolment initiation (NCT00877955)